Completing data — refresh the page later to see the latest
15750-15-9[111In]APFVFJFRJDLVQX-AHCXROLUSA-NIndium In-111 is under investigation in clinical trial NCT00493454 (Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas).
15750-15-9DTXSID001019286Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Indium-111
Radioactive material
Atomic number: 49